We are an effective voice for EB and other rare diseases among our elected leaders, government agencies, as well as private industry groups, who have called on us to speak at rare disease policy conferences, on Capitol Hill, and at State Capitols.
We have developed a long-term strategy to benefit the EB Community. We’ve secured bi-partisan support at the federal and state levels for the cause, as well as developed key relationships with government agencies such as the National Institutes of Health (NIH). We’ve also deepened our existing partnerships with other advocacy organizations, such as Research!America, EveryLife Foundation for Rare Diseases, and the Rare Disease Legislative Advocates.